|ITEM METADATA RECORD
|Title: ||Analysis of Blood Plasma Factors in the AVITA Phase III Randomized Study of Bevacizumab (bev) With Gemcitabine-Erlotinib (GE) in Patients (pts) With Metastatic Pancreatic Cancer (mPC)|
|Authors: ||Van Cutsem, Eric|
de Haas, S
Scherer, S. J #
|Issue Date: ||Sep-2011 |
|Host Document: ||European Journal of Cancer vol:47 pages:S95-S96|
|Conference: ||European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care location:Stockholm, SWEDEN date:SEP 23-27, 2011|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Clinical Digestive Oncology (+)|
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.
© Web of science